494799-19-8 Usage
Description
Methyl 2-Bromo-3-cyclohexyl-6-indolecarboxylate is an indole derivative characterized by its unique chemical structure, which features a cyclohexyl group at the 3-position and a bromo substituent at the 2-position. Methyl 2-Bromo-3-cyclohexyl-6-indolecarboxylate is known for its potential applications in the pharmaceutical and chemical industries due to its specific properties and reactivity.
Uses
Used in Pharmaceutical Industry:
Methyl 2-Bromo-3-cyclohexyl-6-indolecarboxylate is used as an antiviral agent for the treatment of hepatitis C virus (HCV) infection. Its indole-based structure allows it to interact with specific viral targets, inhibiting the replication and spread of the virus within the host. This makes it a valuable compound in the development of new therapeutic strategies against HCV.
Additionally, due to its chemical reactivity and structural diversity, Methyl 2-Bromo-3-cyclohexyl-6-indolecarboxylate can be further modified or used as a building block in the synthesis of other bioactive compounds with potential applications in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 494799-19-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,4,7,9 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 494799-19:
(8*4)+(7*9)+(6*4)+(5*7)+(4*9)+(3*9)+(2*1)+(1*9)=228
228 % 10 = 8
So 494799-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C16H18BrNO2/c1-20-16(19)11-7-8-12-13(9-11)18-15(17)14(12)10-5-3-2-4-6-10/h7-10,18H,2-6H2,1H3
494799-19-8Relevant articles and documents
HEPATITIS B CORE PROTEIN MODULATORS
-
, (2018/04/13)
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:
An efficient process for the large-scale synthesis of a 2,3,6-trisubstituted indole
Alorati, Anthony D.,Gibb, Andrew D.,Mullens, Peter R.,Stewart, Gavin W.
, p. 1947 - 1952 (2013/03/14)
The efficient synthesis of a key trisubstituted indole intermediate 1 is described. The synthetic route required the use of an aryl Grignard reagent which was not commercially available, and the large-scale formation of this fragment and the thermal evalu
CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS
-
Page/Page column 40-41, (2009/06/27)
The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV
